Literature DB >> 27374192

Optimal bladder volume at treatment planning for prostate cancer patients receiving volumetric modulated arc therapy.

Chiaki Fujioka1, Kentaro Ishii2, Toshiko Yamanaga2, Ryo Ogino2, Shun Kishimoto2, Ryu Kawamorita2, Takuhito Tada3, Toshifumi Nakajima2.   

Abstract

PURPOSE: To investigate optimal bladder volumes at treatment planning (TP) in prostate cancer patients who undergo volumetric modulated arc therapy (VMAT). METHODS AND MATERIALS: To determine the minimum value, 122 patients were classified into 6 groups according to the bladder volume at TP: <100 mL (group 1), 100-149 mL (group 2), 150-199 mL (group 3), 200-249 mL (group 4), 250-299 mL (group 5), and ≥300 mL (group 6). Bladder volumes receiving more than 70 Gy (V70Gy) and V50Gy were calculated in each subgroup and compared with the bladder dose-volume constraints specified in our institution. To determine the maximum value, 64 patients who underwent uniform nursing interventions were classified into the same 6 groups. Bladder volumes on cone beam computed tomography (CBCT) images were measured once weekly during treatment, for a total of 8 measurements. Relative bladder volumes (bladder volume on CBCT image [mL]/bladder volume at TP [mL] × 100%) were evaluated in each of the 6 subgroups.
RESULTS: The upper bounds of the 95% confidence intervals of the mean V70Gy and V50Gy values in group 1 exceeded the dose constraints at our institution. The mean relative bladder volumes were 104%, 91%, 77%, 81%, 63%, and 59% in groups 1, 2, 3, 4, 5, and 6, respectively. The institutional criterion of 70% for the mean relative bladder volume was achieved in groups 1-4, but it could not be achieved in groups 5-6. Therefore, the patients in groups 2-4 met both institutional dose constraints for the bladder at TP and the institutional criterion for the mean relative bladder volume during treatment.
CONCLUSIONS: The optimal bladder volumes at TP were between 100 and 250 mL in this setting. Nursing intervention needs to be implemented before treatment planning to ensure that patients achieve the optimal bladder volume range.
Copyright © 2016 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27374192     DOI: 10.1016/j.prro.2016.05.007

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  4 in total

1.  Are simple verbal instructions sufficient to ensure that bladder volume does not deteriorate prostate position reproducibility during spot scanning proton therapy?

Authors:  Kentaro Nishioka; Kento Gotoh; Takayuki Hashimoto; Takashige Abe; Takahiro Osawa; Ryuji Matsumoto; Isao Yokota; Norio Katoh; Rumiko Kinoshita; Koichi Yasuda; Toshiaki Yakabe; Takaaki Yoshimura; Seishin Takao; Nobuo Shinohara; Hidefumi Aoyama; Shinichi Shimizu; Hiroki Shirato
Journal:  BJR Open       Date:  2021-11-11

2.  Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer.

Authors:  Arne Grün; Michael Kawgan-Kagan; David Kaul; Harun Badakhshi; Carmen Stromberger; Volker Budach; Dirk Böhmer
Journal:  Strahlenther Onkol       Date:  2018-11-15       Impact factor: 3.621

3.  Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: The dosimetric impact.

Authors:  Gillian Adair Smith; Alex Dunlop; Helen Barnes; Trina Herbert; Rebekah Lawes; Jonathan Mohajer; Alison C Tree; Helen A McNair
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-02-16

4.  Reduction of intra-fraction prostate motion - Determining optimal bladder volume and filling for prostate radiotherapy using daily 4D TPUS and CBCT.

Authors:  Eric Pei Ping Pang; Kellie Knight; Ashik Hussain; Qiao Fan; Marilyn Baird; Sheena Xue Fei Tan; Wing-Ho Mui; Ronnie Wing-Kin Leung; Irene Kai Ling Seah; Zubin Master; Jeffrey Kit Loong Tuan
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2018-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.